{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T06:02:24Z","timestamp":1784440944092,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,18]]},"DOI":"10.7759\/cureus.112935","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:17:09Z","timestamp":1784438229000},"source":"Crossref","is-referenced-by-count":0,"title":["Subclinical Cardiac Remodeling in Borderline Hypertension: The Role of Advanced Imaging"],"prefix":"10.7759","author":[{"given":"Tamar","family":"Gaprindashvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rusudan","family":"Agladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Bochorishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zurab","family":"Pagava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Hypertension. (2024). Accessed. April 10, 2026: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","unstructured":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019. a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021, 398:957-80. 10.1016\/S0140-6736(21)01330-1","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills KT","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020, 16:223-37. 10.1038\/s41581-019-0244-2","journal-title":"Nat Rev Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy D","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990, 322:1561-6. 10.1056\/NEJM199005313222203","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-1017-9","article-title":"Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy","volume":"22","author":"Nwabuo CC","year":"2020","unstructured":"Nwabuo CC, Vasan RS. Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. Curr Hypertens Rep. 2020, 22:11. 10.1007\/s11906-020-1017-9","journal-title":"Curr Hypertens Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21708","article-title":"Myocardial interstitial fibrosis in hypertensive heart disease: from mechanisms to clinical management","volume":"81","author":"Gonz\u00e1lez A","year":"2024","unstructured":"Gonz\u00e1lez A, L\u00f3pez B, Ravassa S, San Jos\u00e9 G, Latasa I, Butler J, D\u00edez J. Myocardial interstitial fibrosis in hypertensive heart disease: from mechanisms to clinical management. Hypertension. 2024, 81:218-28. 10.1161\/HYPERTENSIONAHA.123.21708","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton PK","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al.. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018, 71:e13-e115. 10.1161\/HYP.0000000000000065","journal-title":"Hypertension"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al.. 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018, 39:3021-104. 10.1093\/eurheartj\/ehy339","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia G","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, et al.. 2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023, 41:1874-2071. 10.1097\/HJH.0000000000003480","journal-title":"J Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-177","article-title":"Prehypertension and incidence of cardiovascular disease: a meta-analysis","volume":"11","author":"Huang Y","year":"2013","unstructured":"Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, Xu D. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013, 11:177. 10.1186\/1741-7015-11-177","journal-title":"BMC Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge C","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019, 4:5. 10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13010137","article-title":"Cardiac magnetic resonance in hypertensive heart disease: time for a new chapter","volume":"13","author":"Zdravkovic M","year":"2022","unstructured":"Zdravkovic M, Klasnja S, Popovic M, et al.. Cardiac magnetic resonance in hypertensive heart disease: time for a new chapter. Diagnostics (Basel). 2022, 13:137. 10.3390\/diagnostics13010137","journal-title":"Diagnostics (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-015-0176-3","article-title":"Extracellular volume quantification in isolated hypertension - changes at the detectable limits?","volume":"17","author":"Treibel TA","year":"2015","unstructured":"Treibel TA, Zemrak F, Sado DM, et al.. Extracellular volume quantification in isolated hypertension - changes at the detectable limits?. J Cardiovasc Magn Reson. 2015, 17:74. 10.1186\/s12968-015-0176-3","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2503093","article-title":"Hypertensive heart disease: mechanisms, diagnosis and treatment","volume":"25","author":"Huang X","year":"2024","unstructured":"Huang X, Hu L, Long Z, Wang X, Wu J, Cai J. Hypertensive heart disease: mechanisms, diagnosis and treatment. Rev Cardiovasc Med. 2024, 25:93. 10.31083\/j.rcm2503093","journal-title":"Rev Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2217\/fca.12.75","article-title":"Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system","volume":"9","author":"Clarke C","year":"2013","unstructured":"Clarke C, Flores-Mu\u00f1oz M, McKinney CA, Milligan G, Nicklin SA. Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system. Future Cardiol. 2013, 9:23-38. 10.2217\/fca.12.75","journal-title":"Future Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza M","year":"2020","unstructured":"Paz Ocaranza M, Riquelme JA, Garc\u00eda L, Jalil JE, Chiong M, Santos RA, Lavandero S. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol. 2020, 17:116-29. 10.1038\/s41569-019-0244-8","journal-title":"Nat Rev Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1377113","article-title":"Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?","volume":"15","author":"\u00c1vila-Mart\u00ednez DV","year":"2024","unstructured":"\u00c1vila-Mart\u00ednez DV, Mixtega-Ruiz WK, Hurtado-Capetillo JM, Lopez-Franco O, Flores-Mu\u00f1oz M. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?. Front Pharmacol. 2024, 15:1377113. 10.3389\/fphar.2024.1377113","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension","volume":"72","author":"Gonz\u00e1lez A","year":"2018","unstructured":"Gonz\u00e1lez A, Ravassa S, L\u00f3pez B, et al.. Myocardial remodeling in hypertension. Hypertension. 2018, 72:549-58. 10.1161\/HYPERTENSIONAHA.118.11125","journal-title":"Hypertension"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jes071","article-title":"Association of abnormal coronary microcirculatory function with impaired response of longitudinal left ventricular function during adenosine stress echocardiography in untreated hypertensive patients","volume":"13","author":"Ikonomidis I","year":"2012","unstructured":"Ikonomidis I, Tzortzis S, Paraskevaidis I, et al.. Association of abnormal coronary microcirculatory function with impaired response of longitudinal left ventricular function during adenosine stress echocardiography in untreated hypertensive patients. Eur Heart J Cardiovasc Imaging. 2012, 13:1030-40. 10.1093\/ehjci\/jes071","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093122","article-title":"Hypertensive heart disease - the imaging perspective","volume":"12","author":"Ismail TF","year":"2023","unstructured":"Ismail TF, Frey S, Kaufmann BA, Winkel DJ, Boll DT, Zellweger MJ, Haaf P. Hypertensive heart disease - the imaging perspective. J Clin Med. 2023, 12:3122. 10.3390\/jcm12093122","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux091","article-title":"Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE)","volume":"19","author":"Lip GY","year":"2017","unstructured":"Lip GY, Coca A, Kahan T, et al.. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulaci\u00f3n Card\u00edaca y Electrofisiolog\u00eda (SOLEACE). Europace. 2017, 19:891-911. 10.1093\/europace\/eux091","journal-title":"Europace"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175723","article-title":"Hypertensive heart disease: a narrative review series - part 2: macrostructural and functional abnormalities","volume":"12","author":"Nemtsova V","year":"2023","unstructured":"Nemtsova V, Burkard T, Vischer AS. Hypertensive heart disease: a narrative review series - part 2: macrostructural and functional abnormalities. J Clin Med. 2023, 12:5723. 10.3390\/jcm12175723","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1460826","article-title":"Association between myocardial layer-specific strain and high 10-year risk of atherosclerotic cardiovascular disease in hypertension-findings from the China-PAR project study","volume":"11","author":"Chen J","year":"2024","unstructured":"Chen J, Yang X, Li X, et al.. Association between myocardial layer-specific strain and high 10-year risk of atherosclerotic cardiovascular disease in hypertension-findings from the China-PAR project study. Front Cardiovasc Med. 2024, 11:1460826. 10.3389\/fcvm.2024.1460826","journal-title":"Front Cardiovasc Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv529","article-title":"Myocardial strain imaging: how useful is it in clinical decision making?","volume":"37","author":"Smiseth OA","year":"2016","unstructured":"Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making?. Eur Heart J. 2016, 37:1196-207. 10.1093\/eurheartj\/ehv529","journal-title":"Eur Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.81.3.815","article-title":"Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy","volume":"81","author":"Levy D","year":"1990","unstructured":"Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990, 81:815-20. 10.1161\/01.cir.81.3.815","journal-title":"Circulation"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.12.035","article-title":"Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"159","author":"Jain A","year":"2010","unstructured":"Jain A, Tandri H, Dalal D, et al.. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2010, 159:652-8. 10.1016\/j.ahj.2009.12.035","journal-title":"Am Heart J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.037","article-title":"Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy","volume":"69","author":"Peguero JG","year":"2017","unstructured":"Peguero JG, Lo Presti S, Perez J, Issa O, Brenes JC, Tolentino A. Electrocardiographic criteria for the diagnosis of left ventricular hypertrophy. J Am Coll Cardiol. 2017, 69:1694-703. 10.1016\/j.jacc.2017.01.037","journal-title":"J Am Coll Cardiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues F","year":"2002","unstructured":"Grothues F, Smith GC, Moon JC, et al.. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002, 90:29-34. 10.1016\/s0002-9149(02)02381-0","journal-title":"Am J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/echo.12303","article-title":"Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis","volume":"31","author":"Armstrong AC","year":"2014","unstructured":"Armstrong AC, Gjesdal O, Almeida A, et al.. Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis. Echocardiography. 2014, 31:12-20. 10.1111\/echo.12303","journal-title":"Echocardiography"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeu184","article-title":"Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging","volume":"16","author":"Voigt JU","year":"2015","unstructured":"Voigt JU, Pedrizzetti G, Lysyansky P, et al.. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015, 16:1-11. 10.1093\/ehjci\/jeu184","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2015.06.011","article-title":"Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI\/ASE Inter-Vendor Comparison Study","volume":"28","author":"Farsalinos KE","year":"2015","unstructured":"Farsalinos KE, Daraban AM, \u00dcnl\u00fc S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI\/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr. 2015, 28:1171-1181, e2. 10.1016\/j.echo.2015.06.011","journal-title":"J Am Soc Echocardiogr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309576","article-title":"Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes","volume":"102","author":"Rodrigues JC","year":"2016","unstructured":"Rodrigues JC, Amadu AM, Dastidar AG, et al.. Comprehensive characterisation of hypertensive heart disease left ventricular phenotypes. Heart. 2016, 102:1671-9. 10.1136\/heartjnl-2016-309576","journal-title":"Heart"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2016.00049","article-title":"T1 mapping for myocardial fibrosis by cardiac magnetic resonance relaxometry - a comprehensive technical review","volume":"3","author":"Hamilton-Craig CR","year":"2016","unstructured":"Hamilton-Craig CR, Strudwick MW, Galloway GJ. T1 mapping for myocardial fibrosis by cardiac magnetic resonance relaxometry - a comprehensive technical review. Front Cardiovasc Med. 2016, 3:49. 10.3389\/fcvm.2016.00049","journal-title":"Front Cardiovasc Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-92","article-title":"Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement","volume":"15","author":"Moon JC","year":"2013","unstructured":"Moon JC, Messroghli DR, Kellman P, et al.. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013, 15:92. 10.1186\/1532-429X-15-92","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2174\/18741924-v16-e221202-2022-8","article-title":"Predictors of impaired left ventricular global longitudinal strain in patients with essential hypertension and preserved ejection fraction","volume":"16","author":"Noori AA","year":"2022","unstructured":"Noori AA, Barzani MA. Predictors of impaired left ventricular global longitudinal strain in patients with essential hypertension and preserved ejection fraction. Open Cardiovasc Med J. 2022, 16:e221202. 10.2174\/18741924-v16-e221202-2022-8","journal-title":"Open Cardiovasc Med J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-021-00186-y","article-title":"Role of strain echocardiography in patients with hypertension","volume":"28","author":"Oh JK","year":"2022","unstructured":"Oh JK, Park JH. Role of strain echocardiography in patients with hypertension. Clin Hypertens. 2022, 28:6. 10.1186\/s40885-021-00186-y","journal-title":"Clin Hypertens"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003079","article-title":"Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis","volume":"40","author":"Tadic M","year":"2022","unstructured":"Tadic M, Gherbesi E, Sala C, Carugo S, Cuspidi C. Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis. J Hypertens. 2022, 40:641-7. 10.1097\/HJH.0000000000003079","journal-title":"J Hypertens"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen City Heart Study","volume":"10","author":"Biering-S\u00f8rensen T","year":"2017","unstructured":"Biering-S\u00f8rensen T, Biering-S\u00f8rensen SR, Olsen FJ, et al.. Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the Copenhagen City Heart Study. Circ Cardiovasc Imaging. 2017, 10:e005521. 10.1161\/CIRCIMAGING.116.005521","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092708","article-title":"Challenges in echocardiography for the diagnosis and prognosis of non-ischemic hypertensive heart disease","volume":"13","author":"Kadoglou NP","year":"2024","unstructured":"Kadoglou NP, Mouzarou A, Hadjigeorgiou N, Korakianitis I, Myrianthefs MM. Challenges in echocardiography for the diagnosis and prognosis of non-ischemic hypertensive heart disease. J Clin Med. 2024, 13:2708. 10.3390\/jcm13092708","journal-title":"J Clin Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-017-4841-9","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling","volume":"27","author":"Wang S","year":"2017","unstructured":"Wang S, Hu H, Lu M, et al.. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Eur Radiol. 2017, 27:4620-30. 10.1007\/s00330-017-4841-9","journal-title":"Eur Radiol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.2020190214","article-title":"Detection of myocardial fibrosis and left ventricular dysfunction with cardiac MRI in a hypertensive swine model","volume":"2","author":"Zhuang B","year":"2020","unstructured":"Zhuang B, Cui C, Sirajuddin A, et al.. Detection of myocardial fibrosis and left ventricular dysfunction with cardiac MRI in a hypertensive swine model. Radiol Cardiothorac Imaging. 2020, 2:e190214. 10.1148\/ryct.2020190214","journal-title":"Radiol Cardiothorac Imaging"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16696-0","article-title":"T1 values and extracellular volume fraction in asymptomatic subjects: variations in left ventricular segments and correlation with cardiovascular risk factors","volume":"12","author":"Kim MY","year":"2022","unstructured":"Kim MY, Cho SJ, Kim HJ, Kim SM, Lee SC, Paek M, Choe YH. T1 values and extracellular volume fraction in asymptomatic subjects: variations in left ventricular segments and correlation with cardiovascular risk factors. Sci Rep. 2022, 12:12544. 10.1038\/s41598-022-16696-0","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/hearts6030022","article-title":"Systematic review and meta-analysis of cardiac MRI T1 and ECV measurements in pre-heart failure populations","volume":"6","author":"Doyle RS","year":"2025","unstructured":"Doyle RS, Walsh R, Walsh J, Temperley HC, McCormick J, Giblin G. Systematic review and meta-analysis of cardiac MRI T1 and ECV measurements in pre-heart failure populations. Hearts. 2025, 6:22. 10.3390\/hearts6030022","journal-title":"Hearts"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.09.061","article-title":"The 2013 ACC\/AHA risk score and subclinical cardiac remodeling and dysfunction: complementary in cardiovascular disease prediction","volume":"297","author":"Cauwenberghs N","year":"2019","unstructured":"Cauwenberghs N, Hedman K, Kobayashi Y, Vanassche T, Haddad F, Kuznetsova T. The 2013 ACC\/AHA risk score and subclinical cardiac remodeling and dysfunction: complementary in cardiovascular disease prediction. Int J Cardiol. 2019, 297:67-74. 10.1016\/j.ijcard.2019.09.061","journal-title":"Int J Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2019.09.10","article-title":"Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world","volume":"10","author":"Ojji D","year":"2020","unstructured":"Ojji D, Libhaber E, Lamont K, Thienemann F, Sliwa K. Circulating biomarkers in the early detection of hypertensive heart disease: usefulness in the developing world. Cardiovasc Diagn Ther. 2020, 10:296-304. 10.21037\/cdt.2019.09.10","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14175935","article-title":"Evaluating the prognostic significance of circulating biomarkers of end organ damage in hypertension","volume":"14","author":"Mbeta E","year":"2025","unstructured":"Mbeta E, Williams K, Yates J, Sankaranarayanan R, Penson P, Lip GY, McDowell G. Evaluating the prognostic significance of circulating biomarkers of end organ damage in hypertension. J Clin Med. 2025, 14:5935. 10.3390\/jcm14175935","journal-title":"J Clin Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-026-01123-y","article-title":"Natriuretic peptides and cardiac troponins in hypertension and heart failure: a contemporary review of the evidence","volume":"40","author":"Cai A","year":"2026","unstructured":"Cai A, Bayes-Genis A, Parati G. Natriuretic peptides and cardiac troponins in hypertension and heart failure: a contemporary review of the evidence. J Hum Hypertens. 2026, 40:239-56. 10.1038\/s41371-026-01123-y","journal-title":"J Hum Hypertens"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.06.009","article-title":"State-of-the-art deep learning in cardiovascular image analysis","volume":"12","author":"Litjens G","year":"2019","unstructured":"Litjens G, Ciompi F, Wolterink JM, de Vos BD, Leiner T, Teuwen J, I\u0161gum I. State-of-the-art deep learning in cardiovascular image analysis. JACC Cardiovasc Imaging. 2019, 12:1549-65. 10.1016\/j.jcmg.2019.06.009","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2308256","article-title":"Artificial intelligence in echocardiography: the time is now","volume":"23","author":"Sehly A","year":"2022","unstructured":"Sehly A, Jaltotage B, He A, et al.. Artificial intelligence in echocardiography: the time is now. Rev Cardiovasc Med. 2022, 23:256.","journal-title":"Rev Cardiovasc Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2026.1761335","article-title":"Artificial intelligence-enhanced electrocardiography for identifying subclinical left ventricular dysfunction in hypertensive individuals: a comprehensive clinical evaluation","volume":"13","author":"Bayraktar MF","year":"2026","unstructured":"Bayraktar MF. Artificial intelligence-enhanced electrocardiography for identifying subclinical left ventricular dysfunction in hypertensive individuals: a comprehensive clinical evaluation. Front Cardiovasc Med. 2026, 13:1761335. 10.3389\/fcvm.2026.1761335","journal-title":"Front Cardiovasc Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02971-2","article-title":"Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging","volume":"30","author":"Wang YJ","year":"2024","unstructured":"Wang YJ, Yang K, Wen Y, et al.. Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging. Nat Med. 2024, 30:1471-80. 10.1038\/s41591-024-02971-2","journal-title":"Nat Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.122.014519","article-title":"Explainable artificial intelligence and cardiac imaging: toward more interpretable models","volume":"16","author":"Salih A","year":"2023","unstructured":"Salih A, Boscolo Galazzo I, Gkontra P, Lee AM, Lekadir K, Raisi-Estabragh Z, Petersen SE. Explainable artificial intelligence and cardiac imaging: toward more interpretable models. Circ Cardiovasc Imaging. 2023, 16:e014519. 10.1161\/CIRCIMAGING.122.014519","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli DR","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, et al.. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017, 19:75. 10.1186\/s12968-017-0389-8","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01622-w","article-title":"The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy","volume":"47","author":"Kario K","year":"2024","unstructured":"Kario K, Okura A, Hoshide S, Mogi M. The WHO Global report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. 2024, 47:1099-102. 10.1038\/s41440-024-01622-w","journal-title":"Hypertens Res"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.06.030","article-title":"Machine learning for data-driven discovery: the rise and relevance","volume":"12","author":"Sengupta PP","year":"2019","unstructured":"Sengupta PP, Shrestha S. Machine learning for data-driven discovery: the rise and relevance. JACC Cardiovasc Imaging. 2019, 12:690-2. 10.1016\/j.jcmg.2018.06.030","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/507473-subclinical-cardiac-remodeling-in-borderline-hypertension-the-role-of-advanced-imaging","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T05:17:11Z","timestamp":1784438231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/507473-subclinical-cardiac-remodeling-in-borderline-hypertension-the-role-of-advanced-imaging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.112935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,18]]}}}